[ Price : $8.95]
HHS deputy general counsel Bob Fox Foster says FDAs chief counsel post will remain vacant until after president Trumps nominee, We...[ Price : $8.95]
FDA designates Formycons FYB202/Otulfi (ustekinumab-aauz) as an interchangeable biosimilar to Janssens reference biologic Stelara ...[ Price : $8.95]
FDA deputy commissioner for policy, legislation, and international affairs Grace Graham highlights major changes coming to FDA und...[ Price : $8.95]
Ionis Pharmaceuticals reports positive topline results from the Essence study of olezarsen in people with moderate hypertriglyceri...[ Price : $8.95]
FDA approves a Novavax BLA for traditional approval of Nuvaxovid for active immunization to prevent Covid-19 that includes a more ...[ Price : $8.95]
An FDA safety alert warns that patients who stop taking oral allergy medicines cetirizine or levocetirizine after long-term use ma...[ Price : $8.95]
FDA clears a Stryker 510(k) for its OptaBlate basivertebral nerve ablation system and its use for procedures providing vertebrogen...[ Price : $8.95]
FDA lifts a clinical hold against Scynexiss ibrexafungerp that will allow it to proceed with its Phase 3 MARIO study in invasive c...